Hitoshi Sekikawa

632 total citations
37 papers, 554 citations indexed

About

Hitoshi Sekikawa is a scholar working on Pharmaceutical Science, Pharmacology and Organic Chemistry. According to data from OpenAlex, Hitoshi Sekikawa has authored 37 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmaceutical Science, 13 papers in Pharmacology and 7 papers in Organic Chemistry. Recurrent topics in Hitoshi Sekikawa's work include Drug Solubulity and Delivery Systems (14 papers), Analytical Methods in Pharmaceuticals (7 papers) and Pharmacological Effects of Natural Compounds (6 papers). Hitoshi Sekikawa is often cited by papers focused on Drug Solubulity and Delivery Systems (14 papers), Analytical Methods in Pharmaceuticals (7 papers) and Pharmacological Effects of Natural Compounds (6 papers). Hitoshi Sekikawa collaborates with scholars based in Japan and United Kingdom. Hitoshi Sekikawa's co-authors include Takaichi Arita, Masahiro Nakano, Naomi Yagi, Masahiko Takada, Masahiro Nakano, Ryohei Hori, Keiji Ito, Megumi Itoh, Kazuhiko Juni and Hiroyuki Nagashima and has published in prestigious journals such as Clinical Cancer Research, International Journal of Pharmaceutics and Biological and Pharmaceutical Bulletin.

In The Last Decade

Hitoshi Sekikawa

36 papers receiving 522 citations

Peers

Hitoshi Sekikawa
Galen W. Radebaugh United States
Valentino J. Stella United States
Venkatramana M. Rao United States
Paul J. Niebergall United States
Kevin C. Johnson United States
Vadlamani K. Prasad United States
Hitoshi Sekikawa
Citations per year, relative to Hitoshi Sekikawa Hitoshi Sekikawa (= 1×) peers N. M. Najib

Countries citing papers authored by Hitoshi Sekikawa

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Sekikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Sekikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Sekikawa more than expected).

Fields of papers citing papers by Hitoshi Sekikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Sekikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Sekikawa. The network helps show where Hitoshi Sekikawa may publish in the future.

Co-authorship network of co-authors of Hitoshi Sekikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Sekikawa. A scholar is included among the top collaborators of Hitoshi Sekikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Sekikawa. Hitoshi Sekikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takayama, Tetsuji, Hiroyuki Nagashima, Masahiro Maeda, et al.. (2011). Randomized Double-Blind Trial of Sulindac and Etodolac to Eradicate Aberrant Crypt Foci and to Prevent Sporadic Colorectal Polyps. Clinical Cancer Research. 17(11). 3803–3811. 52 indexed citations
2.
Yagi, Naomi, et al.. (2011). Stability of Probucol-Polyvinylpyrrolidone Solid Dispersion Systems. YAKUGAKU ZASSHI. 131(4). 629–634. 5 indexed citations
3.
Kobayashi, Michiya, Akihide Itoh, Masahiro Tsuji, et al.. (2008). Questionnaire Survey on Use of Health Foods among Hospital Outpatients with Diabetes Mellitus (Part 2): Concurrent Use of Drugs for Diabetes Mellitus and Health Foods. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 34(2). 118–123. 1 indexed citations
4.
Yagi, Naomi, et al.. (2007). Buserelin acetate microparticle dispersion effects drug release and plasma E1 levels. International Journal of Pharmaceutics. 339(1-2). 130–138. 6 indexed citations
5.
Saitoh, Hiroshi, et al.. (2006). A Beneficial Interaction between Imipenem and Piperacillin Possibly through Their Renal Excretory Process. Biological and Pharmaceutical Bulletin. 29(12). 2519–2522. 6 indexed citations
6.
Sekikawa, Hitoshi, et al.. (2005). Assessment of the Use of "Medicine-Pocketbook" at the Pharmacy of the Medical and Dental Clinic of the Health Sciences University of Hokkaido and its Effectiveness in Risk Management. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 31(6). 475–482.
7.
Yagi, Naomi, et al.. (2002). Pharmacokinetics of Ketotifen Fumarate after Intravenous, Intranasal, Oral and Rectal Administration in Rabbits.. Biological and Pharmaceutical Bulletin. 25(12). 1614–1618. 11 indexed citations
8.
Yagi, Naomi, et al.. (1999). Bioavailability and Diuretic Effect after Administration of Retarded Capsules of Bumetanide in Human Subjects.. Biological and Pharmaceutical Bulletin. 22(3). 275–280. 3 indexed citations
9.
Yagi, Naomi, et al.. (1996). Bioavailability and Diuretic Effect of Furosemide Following Administration of Tablets and Retarded Capsules to Human Subjects.. Biological and Pharmaceutical Bulletin. 19(4). 616–622. 6 indexed citations
10.
Yagi, Naomi, et al.. (1996). Dissolution Behavior of Probucol from Solid Dispersion Systems of Probucol-Polyvinylpyrrolidone.. Chemical and Pharmaceutical Bulletin. 44(1). 241–244. 66 indexed citations
11.
Sekikawa, Hitoshi, Naomi Yagi, Emil T. Lin, & Leslie Z. Benet. (1995). Apparent Intramolecular Acyl Migration and Hydrolysis of Furosemide Glucuronide in Aqueous Solution.. Biological and Pharmaceutical Bulletin. 18(1). 134–139. 8 indexed citations
12.
Sekikawa, Hitoshi, et al.. (1995). Biliary Excretion of Furosemide Glucuronide in Rabbits.. Biological and Pharmaceutical Bulletin. 18(3). 447–453. 7 indexed citations
13.
Suzuki, Ryota, Yuko Nakajima, Naomi Yagi, et al.. (1994). Enhancement of Rectal Absorption of Rifampicin by Sodium para-Aminosalicylate Dihydrate in Human Subjects. YAKUGAKU ZASSHI. 114(11). 894–900. 3 indexed citations
14.
Sekikawa, Hitoshi, et al.. (1994). Sustained Release of Phenytoin Following the Oral Administration of Phenytoin Sodium/Ethylcellulose Microcapsules in Human Subjects and Rabbits.. Biological and Pharmaceutical Bulletin. 17(3). 432–436. 5 indexed citations
15.
Yagi, Naomi, et al.. (1993). Compatibility between Drugs and Photodegradation of Sustained Release Fine Granules of Nifedipine.. Japanese Journal of Hospital Pharmacy. 19(5). 427–434. 1 indexed citations
16.
Yagi, Naomi, et al.. (1993). Bioavailability and Diuretic Effect of Bumetanide Following Rectal Administration of Suppositories Containing Weak Acids in Human Subjects.. Biological and Pharmaceutical Bulletin. 16(11). 1124–1129. 5 indexed citations
17.
Yagi, Naomi, et al.. (1993). Enhanced Absorption of Bumetanide from Suppositories Containing Weak Acids in Rabbits.. Biological and Pharmaceutical Bulletin. 16(3). 263–267. 3 indexed citations
18.
Itoh, Megumi, Masahiro Nakano, Kazuhiko Juni, & Hitoshi Sekikawa. (1980). Sustained release of sulfamethizole, 5-fluorouracil, and doxorubicin from ethylcellulose-polylactic acid microcapsules.. Chemical and Pharmaceutical Bulletin. 28(4). 1051–1055. 14 indexed citations
19.
Sekikawa, Hitoshi, Masahiro Nakano, & Takaichi Arita. (1978). Inhibitory effect of polyvinylpyrrolidone on the crystallization of drugs.. Chemical and Pharmaceutical Bulletin. 26(1). 118–126. 122 indexed citations
20.
Sekikawa, Hitoshi, Ryohei Hori, Takaichi Arita, Keiji Ito, & Masahiro Nakano. (1978). Application of the cloud point method to the study of the interaction of polyvinylpyrrolidone with some organic compounds in aqueous solution.. Chemical and Pharmaceutical Bulletin. 26(8). 2489–2496. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026